Caribou Biosciences cut to sector perform from outperform; price target lowered to $1 from $10
CRBU•RBC cut its rating on Caribou Biosciences to sector perform from outperform and lowered its price target to $1 from $10.
Related News
Fidelity National Financial: KBW cuts target price to $53 from $61
FNF•
Miami International Holdings: KBW cuts target price to $35 from $48
MIAX•
Jefferies raises Exelixis target price to $70 from $66
EXEL•
Rocket Companies: KBW cuts target price to $17.00 from $19.00
RKT•
PennyMac Mortgage Investment Trust: KBW cuts target price to $10.75 from $12.00
PMT•